⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Novalix and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Novalix
↗Strasbourg, France
Novalix is a premier contract research organization (CRO) dedicated to the early stages of drug discovery. Founded in 2002 and headquartered in Strasbourg, France, the company provides a comprehensive portfolio of services including medicinal chemistry, biophysics, pharmacology, and drug metabolism and pharmacokinetics (DMPK).
The company distinguishes itself through its expertise in structural biology, AI-driven DNA-encoded library (DEL) technology, and cryo-electron microscopy (Cryo-EM). Novalix operates as a collaborative partner for biotech and pharmaceutical firms, supporting projects from target validation through to preclinical candidate selection.
CLASSIFICATION
SIZE & FINANCIALS
Employees:201-500
Revenue:$20M-$30M
Founded:2002
Ownership:private
Status:operating
FUNDING
Investors:Bruker (minority stake)
PIPELINE
Stage:Discovery
Lead Drug Stage:N/A (CRO)
Modalities:Small molecule, PROTACs
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Novalix Japan KK
Key Partnerships:Galapagos NV (Research and discovery collaboration), Bruker (Strategic alliance), Sanofi (Acquisition of research facility)
COMPETITION
Position:Niche Player
Competitors:Sai Life Sciences, Acies Bio, Liverpool ChiroChem
LEADERSHIP
Key Executives:
Stephan Jenn - President
Laurent Saniere - Senior VP and Head of Drug Discovery
Scientific Founders:Jean-Paul Renaud, D. Moras
LINKS
Website:novalix.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Novalix. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.